179 related articles for article (PubMed ID: 25052559)
1. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
Cotterchio M; Mirea L; Ozcelik H; Kreiger N
Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
[TBL] [Abstract][Full Text] [Related]
2. Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers.
Anderson LN; Cotterchio M; Mirea L; Ozcelik H; Kreiger N
Am J Epidemiol; 2012 Feb; 175(4):289-301. PubMed ID: 22247046
[TBL] [Abstract][Full Text] [Related]
3. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer.
Shields PG; Ambrosone CB; Graham S; Bowman ED; Harrington AM; Gillenwater KA; Marshall JR; Vena JE; Laughlin R; Nemoto T; Freudenheim JL
Mol Carcinog; 1996 Nov; 17(3):144-50. PubMed ID: 8944074
[TBL] [Abstract][Full Text] [Related]
4. High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
Lowcock EC; Cotterchio M; Anderson LN; Boucher BA; El-Sohemy A
Nutr Cancer; 2013; 65(3):398-409. PubMed ID: 23530639
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cleary SP; Cotterchio M; Shi E; Gallinger S; Harper P
Am J Epidemiol; 2010 Nov; 172(9):1000-14. PubMed ID: 20937634
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer.
Band PR; Le ND; Fang R; Deschamps M
Lancet; 2002 Oct; 360(9339):1044-9. PubMed ID: 12383984
[TBL] [Abstract][Full Text] [Related]
8. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
9. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
[TBL] [Abstract][Full Text] [Related]
12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
13. Association between allergies, asthma, and breast cancer risk among women in Ontario, Canada.
Lowcock EC; Cotterchio M; Ahmad N
Cancer Causes Control; 2013 May; 24(5):1053-6. PubMed ID: 23443321
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk.
Zheng W; Deitz AC; Campbell DR; Wen WQ; Cerhan JR; Sellers TA; Folsom AR; Hein DW
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):233-9. PubMed ID: 10090301
[TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
[TBL] [Abstract][Full Text] [Related]
18. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.
Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey AB; Harper PA
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3098-107. PubMed ID: 18990750
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
